Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

Adaptive trials allow for modifications to be made during the trial without requiring additional approvals. According to the ...

An experimental drug empowered by artificial intelligence to identify a novel therapeutic target for a severe lung disease ...

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines, confirming a ...

Scipher Medicine, a precision immunology company dedicated to transforming patient care through data-driven insights, today announced a strategic collaboration with a top 3 global pharmaceutical ...

Ibogaine is a plant-based psychedelic substance that's extracted from the roots of an iboga plant. It has been used in ...

Results from a first-in-human Phase Ia/Ib trial show that LY4170156 demonstrated a notably high overall response rate in ...

A study in Nature Communications reveals, for the first time, how the transcriptomic profile of human tuberculosis lung ...

A drug used for high blood pressure, known as rilmenidine, may also be effective in slowing the aging process, even in older ...

There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...

Artificial Intelligence in Drug Discovery Market Advancements Artificial Intelligence for Drug Discovery Market Research Report Information ...